TCF3-PBX1 fusion
|
B Acute Lymphoblastic Leukemia
|
TCF3-PBX1 fusion
|
B Acute Lymphoblastic Leukemia
|
idelalisib Sensitive: C3 – Early Trials
|
idelalisib Sensitive: C3 – Early Trials
|
TCF3-PBX1 fusion
|
B Acute Lymphoblastic Leukemia
|
TCF3-PBX1 fusion
|
B Acute Lymphoblastic Leukemia
|
CD19-targeted CAR-T immunotherapy Sensitive: C4 – Case Studies
|
CD19-targeted CAR-T immunotherapy Sensitive: C4 – Case Studies
|
TCF3-PBX1 fusion
|
B Acute Lymphoblastic Leukemia
|
TCF3-PBX1 fusion
|
B Acute Lymphoblastic Leukemia
|
OSE-127 Sensitive: D – Preclinical
|
OSE-127 Sensitive: D – Preclinical
|